Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells - PubMed (original) (raw)
Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells
M J Allday et al. J Gen Virol. 1993 Mar.
Abstract
Epstein-Barr virus (EBV) nuclear antigen (EBNA) 6 (also known as 3c) is a latent nuclear protein with an M(r) of about 160K which is invariably expressed in EBV-immortalized B cells. It includes a putative basic leucine zipper domain; as such it is a good candidate for a regulator of viral gene expression. More than 75% of the EBNA 6 coding sequence is deleted from viral genomes carried in the Burkitt's lymphoma (BL) tumour-derived cell line, Raji. Thus although Raji cells express normal levels of the remaining five EBNAs and low levels of latent membrane protein (LMP), EBNA 6 protein is completely absent. In this study we have established Raji clones stably expressing EBNA 6 after cotransfection of an EBNA 6 gene under the control of the simian virus 40 early promoter with a selectable marker. Analysis of these clones has revealed that EBNA 6 induces a significant increase in the expression of LMP. In addition the cells have undergone a number of morphological and phenotypic changes consistent with blast-activation of normal B lymphocytes. The Raji cells expressing EBNA 6 show ruffling of the cell membrane and the development of a polarity defined by multiple villous ('spiky') projections at one end of the cell. This morphological change is associated with a dramatic increase in the expression of the cytoskeletal protein, vimentin. The EBV-associated B cell activation marker CD23 (blast 2) is induced to high levels although other activation markers such as CD30 and CD39 are unaffected. All these changes appear to be independent of the precise levels of EBNA 6 protein expressed. EBNA 2 has been shown previously to trans-activate the LMP gene and in the control Raji cells, EBNA 6-positive Raji cells and in B lymphoblastoid cells similar levels of EBNA 2 are expressed. Our findings are therefore most consistent with a model in which EBNA 6 either augments or complements the action of EBNA 2 in the induction of LMP and the cascade of gene expression which leads to B cell activation and immortalization by EBV.
Similar articles
- Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
Wang F, Gregory C, Sample C, Rowe M, Liebowitz D, Murray R, Rickinson A, Kieff E. Wang F, et al. J Virol. 1990 May;64(5):2309-18. doi: 10.1128/JVI.64.5.2309-2318.1990. J Virol. 1990. PMID: 2157887 Free PMC article. - Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
Gregory CD, Rowe M, Rickinson AB. Gregory CD, et al. J Gen Virol. 1990 Jul;71 ( Pt 7):1481-95. doi: 10.1099/0022-1317-71-7-1481. J Gen Virol. 1990. PMID: 2165133 - The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus.
Ernberg I, Falk K, Minarovits J, Busson P, Tursz T, Masucci MG, Klein G. Ernberg I, et al. J Gen Virol. 1989 Nov;70 ( Pt 11):2989-3002. doi: 10.1099/0022-1317-70-11-2989. J Gen Virol. 1989. PMID: 2479717 - Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1.
Kis LL, Takahara M, Nagy N, Klein G, Klein E. Kis LL, et al. Immunol Lett. 2006 Apr 15;104(1-2):83-8. doi: 10.1016/j.imlet.2005.11.003. Epub 2005 Dec 1. Immunol Lett. 2006. PMID: 16386314 Review. - T cell recognition of Epstein-Barr virus associated lymphomas.
Rickinson AB, Murray RJ, Brooks J, Griffin H, Moss DJ, Masucci MG. Rickinson AB, et al. Cancer Surv. 1992;13:53-80. Cancer Surv. 1992. PMID: 1330300 Review.
Cited by
- EBV-encoded EBNA-6 binds and targets MRS18-2 to the nucleus, resulting in the disruption of pRb-E2F1 complexes.
Kashuba E, Yurchenko M, Yenamandra SP, Snopok B, Isaguliants M, Szekely L, Klein G. Kashuba E, et al. Proc Natl Acad Sci U S A. 2008 Apr 8;105(14):5489-94. doi: 10.1073/pnas.0801053105. Epub 2008 Apr 7. Proc Natl Acad Sci U S A. 2008. PMID: 18391203 Free PMC article. - Intron retention may regulate expression of Epstein-Barr virus nuclear antigen 3 family genes.
Kienzle N, Young DB, Liaskou D, Buck M, Greco S, Sculley TB. Kienzle N, et al. J Virol. 1999 Feb;73(2):1195-204. doi: 10.1128/JVI.73.2.1195-1204.1999. J Virol. 1999. PMID: 9882321 Free PMC article. - Silencing of the Epstein-Barr virus latent membrane protein 1 gene by the Max-Mad1-mSin3A modulator of chromatin structure.
Sjöblom-Hallén A, Yang W, Jansson A, Rymo L. Sjöblom-Hallén A, et al. J Virol. 1999 Apr;73(4):2983-93. doi: 10.1128/JVI.73.4.2983-2993.1999. J Virol. 1999. PMID: 10074148 Free PMC article. - Epstein-Barr virus nuclear antigen 3C is a transcriptional regulator.
Marshall D, Sample C. Marshall D, et al. J Virol. 1995 Jun;69(6):3624-30. doi: 10.1128/JVI.69.6.3624-3630.1995. J Virol. 1995. PMID: 7745710 Free PMC article. - Epstein-Barr virus nuclear antigen EBNA3C/6 expression maintains the level of latent membrane protein 1 in G1-arrested cells.
Allday MJ, Farrell PJ. Allday MJ, et al. J Virol. 1994 Jun;68(6):3491-8. doi: 10.1128/JVI.68.6.3491-3498.1994. J Virol. 1994. PMID: 8189488 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials